Free tool
FAERS Monitor: Efudex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016831 or its brand name (Efudex, Fluorouracil). Reports on generic versions are filed under their own applications.
Reports
78,543
Serious
74,311
95% of reports
Hospitalization
31,520
Death reported
11,050
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea7,137
- neutropenia5,297
- nausea5,119
- vomiting4,068
- off label use3,678
- neuropathy peripheral3,555
- fatigue3,389
- disease progression3,309
- pyrexia3,112
- thrombocytopenia3,047
- febrile neutropenia2,927
- anaemia2,621
- asthenia2,616
- drug ineffective2,265
- malignant neoplasm progression2,227
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,703 |
| 2005 | 1,704 |
| 2006 | 1,406 |
| 2007 | 1,604 |
| 2008 | 1,857 |
| 2009 | 1,828 |
| 2010 | 1,703 |
| 2011 | 2,392 |
| 2012 | 2,883 |
| 2013 | 2,259 |
| 2014 | 1,910 |
| 2015 | 2,410 |
| 2016 | 2,814 |
| 2017 | 3,247 |
| 2018 | 4,962 |
| 2019 | 5,194 |
| 2020 | 4,341 |
| 2021 | 4,338 |
| 2022 | 5,780 |
| 2023 | 6,345 |
| 2024 | 6,025 |
| 2025 | 6,733 |
| 2026 | 5,105 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,975,616 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 2,927 | 12.3 | 11.9 | 29,169 |
| neutropeniaSignal | 5,297 | 10.8 | 10.5 | 45,629 |
| neuropathy peripheralSignal | 3,555 | 10.4 | 10.0 | 29,053 |
| disease progressionSignal | 3,309 | 7.7 | 7.4 | 18,773 |
| thrombocytopeniaSignal | 3,047 | 7.5 | 7.2 | 16,701 |
| malignant neoplasm progressionSignal | 2,227 | 5.9 | 5.7 | 8,969 |
| anaemiaSignal | 2,621 | 3.7 | 3.6 | 5,179 |
| diarrhoeaSignal | 7,137 | 3.0 | 2.9 | 9,595 |
| pyrexiaSignal | 3,112 | 2.4 | 2.3 | 2,614 |
| vomitingSignal | 4,068 | 2.3 | 2.3 | 3,125 |
| asthenia | 2,616 | 1.9 | 1.8 | 1,068 |
| nausea | 5,119 | 1.7 | 1.7 | 1,651 |
| fatigue | 3,389 | 1.2 | 1.1 | 83 |
| off label use | 3,678 | 1.1 | 1.1 | 53 |
| drug ineffective | 2,265 | 0.5 | 0.4 | 1,535 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.